Chad M. Robins
CEO and Chairman at Adaptive Biotechnologies Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Adaptive Biotechnologies Corporation, 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | Adaptive Biotechnologies Corporation | Gift | −100,000 | — | — |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +278,676 | $6.55 | $1,825,328 |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −278,472 | $24.48 | $6,816,995 |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −204 | $25.14 | $5,129 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +321,324 | $6.55 | $2,104,672 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −318,799 | $25.08 | $7,995,479 |
| Aug 17, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −2,525 | $25.57 | $64,564 |
| Apr 8, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −37,263 | $15.19 | $566,025 |
| Apr 6, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −83,332 | $14.41 | $1,200,814 |
| Mar 11, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −140,567 | $13.17 | $1,851,267 |
| Mar 11, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −329,600 | $13.17 | $4,340,832 |
| Mar 6, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +709,220 | — | — |
| Mar 4, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +127,813 | — | — |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −50,703 | $15.49 | $785,389 |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −2,380 | $16.15 | $38,437 |
Questions about Chad M. Robins
What boards is Chad M. Robins on?
Chad M. Robins sits on the board of Adaptive Biotechnologies Corporation.
What company is Chad M. Robins the CEO of?
Chad M. Robins is CEO and Chairman of Adaptive Biotechnologies Corporation.
How long has Chad M. Robins served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.